(Q37269344)

19 August 2017

1 reference

title

Quality-of-life assessment in rheumatoid arthritis (English)

1 reference

19 August 2017

1 reference

1 reference

Anthony S Russell

1

1 reference

19 August 2017

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

26

1 reference

19 August 2017

10

1 reference

19 August 2017

831-846

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200826100-00004

19 August 2017

0 references

cites work

Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis

1 reference

12 December 2020

The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

1 reference

12 December 2020

Quality of life and costs for different treatment strategies for rheumatoid arthritis

1 reference

12 December 2020

The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab

1 reference

12 December 2020

Methods to explain the clinical significance of health status measures

1 reference

12 December 2020

1 reference

12 December 2020

The estimation of a preference-based measure of health from the SF-36.

1 reference

12 December 2020

EuroQol: the current state of play

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

12 December 2020

Limitations of the methods used for calculating quality-adjusted life-year values

1 reference

12 December 2020

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Cost-effectiveness of anti-tumor necrosis factor agents

1 reference

12 December 2020

Quality of life in rheumatoid arthritis

1 reference

12 December 2020

OMERACT 6 brings new perspectives to rheumatology measurement research

1 reference

12 December 2020

Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.

1 reference

12 December 2020

OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritis

1 reference

12 December 2020

Variation in the estimation of quality-adjusted life-years by different preference-based instruments.

1 reference

12 December 2020

Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alpha

1 reference

12 December 2020

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

1 reference

12 December 2020

Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment

1 reference

12 December 2020

The effectiveness of cost-effectiveness analysis in containing costs

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists

1 reference

12 December 2020

Cost of illness studies in rheumatic diseases

1 reference

12 December 2020

Functional disability and quality-of-life assessment in clinical practice

1 reference

12 December 2020

Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis

1 reference

12 December 2020

Adaptation of the RAQoL for use in Australia.

1 reference

12 December 2020

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

12 December 2020

Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

1 reference

12 December 2020

A comparative review of generic quality-of-life instruments

1 reference

12 December 2020

Adaptation and validation of the Turkish version of the Rheumatoid Arthritis Quality of Life Scale

1 reference

12 December 2020

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

12 December 2020

Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

1 reference

12 December 2020

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial

1 reference

12 December 2020

The costs of rheumatoid arthritis

1 reference

12 December 2020

"Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis.

1 reference

12 December 2020

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

12 December 2020

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

12 December 2020

Treating very early rheumatoid arthritis

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

What to do with TNF failures

1 reference

12 December 2020

1 reference

12 December 2020

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

1 reference

12 December 2020

The Stanford Health Assessment Questionnaire: dimensions and practical applications

1 reference

12 December 2020

The use of rheumatoid arthritis health-related quality of life patient questionnaires in clinical practice: lessons learned

1 reference

12 December 2020

The Health Utilities Index (HUI): concepts, measurement properties and applications

1 reference

12 December 2020

Touch-screen computer systems in the rheumatology clinic offer a reliable and user-friendly means of collecting quality-of-life and outcome data from patients with rheumatoid arthritis

1 reference

12 December 2020

Clinical and radiological effects of anakinra in patients with rheumatoid arthritis

1 reference

12 December 2020

Community-based evaluation of etanercept in patients with rheumatoid arthritis

1 reference

12 December 2020

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

12 December 2020

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

12 December 2020

Lack of efficacy of a third tumour necrosis factor α antagonist after failure of a soluble receptor and a monoclonal antibody

1 reference

12 December 2020

Estimating clinically significant differences in quality of life outcomes

1 reference

12 December 2020

A comparison of four indirect methods of assessing utility values in rheumatoid arthritis

1 reference

12 December 2020

AIMS2. The Content and Properties of a Revised and Expanded Arthritis Impact Measurement Scales Health Status Questionnaire

1 reference

12 December 2020

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.

1 reference

12 December 2020

The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument.

1 reference

12 December 2020

Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ)

1 reference

12 December 2020

Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs

1 reference

12 December 2020

Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate.

1 reference

12 December 2020

Rheumatoid arthritis. Designing and implementing a treatment plan

1 reference

12 December 2020

Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

1 reference

12 December 2020

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

12 December 2020

Patient-reported outcomes and their role in the assessment of rheumatoid arthritis

1 reference

12 December 2020

The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization

1 reference

12 December 2020

Adaptation of the rheumatoid arthritis quality of life scale for Estonia

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00019053-200826100-00004

Identifiers

DOI

1 reference

PubMed ID

18793031

Dimensions Publication ID

19 August 2017

0 references

1 reference

PubMed ID

18793031